Bristol Myers Squibb total depreciation and amortization - cash flow for the twelve months ending March 31, 2025 was $23.460B, a 4.05% decline year-over-year.
Bristol Myers Squibb annual total depreciation and amortization - cash flow for 2024 was $9.6B, a 1.64% decline from 2023.
Bristol Myers Squibb annual total depreciation and amortization - cash flow for 2023 was $9.76B, a 5.02% decline from 2022.
Bristol Myers Squibb annual total depreciation and amortization - cash flow for 2022 was $10.276B, a 3.84% decline from 2021.
Bristol Myers Squibb Total Depreciation and Amortization - Cash Flow 2010-2025 | BMY